The Pennant Group’s second quarter was marked by strong revenue growth and a positive market response, reflecting ...

UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid ...

Some members of the federal government remain concerned that the deal will limit home health competition in some areas of the US.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

UnitedHealth will sell 164 healthcare facilities in a DOJ settlement over its Amedisys deal while missing Q2 earnings and ...

The U.S. Department of Justice’s Antitrust Division has filed a proposed settlement requiring United Health to divest of at least 164 home health and hospice facilities to resolve the challenge to its ...

UnitedHealth faced legal challenges last year when the US Justice Department and state attorneys general moved to block the ...

In a report released today, from Oppenheimer maintained a Hold rating on Amedisys. The company’s shares opened today at $99.23. Elevate Your Investing Strategy: Take advantage o ...

The Department of Justice has reached a proposed settlement with UnitedHealth Group and Amedisys regarding UnitedHealth’s ...

Yesterday, the U.S. Department of Justice (DOJ) filed a proposed settlement that would allow UnitedHealth Group (NYSE: UNH) to acquire Amedisys (Nasdaq: ...

UnitedHealth's proposed acquisition of Amedisys faces settlement requiring significant divestitures to maintain market ...

The Pennant Group plans to use UnitedHealth Group’s acquisition of Amedisys to fuel its own expansion in the southeast US.